Premium
Medicenna Therapeutics Corporation (QX) (MDNAF)
USOTC
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | Mr. Angelos GeorgakisDirector | 10,00k | 0,00 | Open Market Derivative Acquisition | - | 10,00k | - |
| 2026-05-28 | Mr. Angelos GeorgakisDirector | 20,00k | 7,24k | Achat | 0,36 | 20,00k | - |
| 2026-05-28 | Mr. Richard SutinDirector | 10,00k | 0,00 | Open Market Derivative Acquisition | - | 10,00k | - |
| 2026-05-28 | Dr. Albert George BeraldoLead Independent Director | 200,00k | 0,00 | Open Market Derivative Acquisition | - | 200,00k | - |
| 2026-05-28 | Dr. Albert George BeraldoLead Independent Director | 400,00k | 144,87k | Achat | 0,36 | 880,11k | 83,31% |
| 2026-05-28 | Dr. Fahar MerchantFounder, Chairman, President & CEO | 55,00k | 0,00 | Open Market Derivative Acquisition | - | 55,00k | - |
| 2026-05-28 | Dr. Fahar MerchantFounder, Chairman, President & CEO | 110,00k | 39,84k | Achat | 0,36 | 5,61M | 2,00% |
| 2026-05-28 | Mr. Richard SutinDirector | 20,00k | 7,24k | Achat | 0,36 | 23,00k | 666,67% |
| 2026-05-28 | Mr. David HymanCFO | 25,00k | 0,00 | Open Market Derivative Acquisition | - | 25,00k | - |
| 2026-05-28 | Mr. David HymanCFO | 50,00k | 1,81k | Achat | 0,04 | 100,00k | 100,00% |
| 2026-03-05 | Mr. Richard SutinDirector | 63,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,65 | 63,00k | - |
| 2026-03-05 | Mr. Angelos GeorgakisDirector | 63,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,65 | 63,00k | - |
| 2026-02-23 | Mr. Richard SutinDirector | 3,00k | 2,15k | Achat | 0,72 | 3,00k | - |
| 2025-12-16 | Dr. Albert George BeraldoLead Independent Director | 3,00k | 2,38k | Achat | 0,79 | 480,11k | 0,63% |
| 2025-12-15 | Dr. Albert George BeraldoLead Independent Director | 85,00k | 68,87k | Achat | 0,81 | 477,11k | 21,68% |
| 2025-12-15 | Dr. Fahar MerchantFounder, Chairman, President & CEO | 32,00k | 25,80k | Achat | 0,81 | 5,84M | 0,55% |
| 2025-12-12 | Mr. David HymanCFO | 10,00k | 8,13k | Achat | 0,81 | 50,00k | 25,00% |
| 2025-12-12 | Dr. Fahar MerchantFounder, Chairman, President & CEO | 15,00k | 12,19k | Achat | 0,81 | 5,81M | 0,26% |
| 2025-11-18 | Dr. Fahar MerchantFounder, Chairman, President & CEO | 350,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,04 | 2,98M | 13,30% |
| 2025-09-25 | Mr. David HymanCFO | 200,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,69 | 600,00k | 50,00% |
| 2025-09-25 | Dr. Fahar MerchantFounder, Chairman, President & CEO | 350,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,69 | 2,63M | 15,35% |
| 2025-09-25 | Mr. Karim F. LaljiIndependent Director | 100,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,69 | 200,00k | 100,00% |
| 2025-09-25 | Ms. Rosemina MerchantFounder & Chief Development Officer | 300,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,69 | 1,81M | 19,84% |
| 2025-09-25 | Dr. John GeltoskyIndependent Director | 100,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,69 | 401,35k | 33,18% |
| 2025-09-25 | Ms. Karen T. DawesInitié | 100,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,69 | 401,35k | 33,18% |
| 2025-09-25 | Dr. Albert George BeraldoLead Independent Director | 100,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,69 | 551,35k | 22,16% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
